Recherche
-
R&D incentives and innovation spillovers: evidence from the European orphan drug regulation.
(8th Biennial Atlanta Conf. on Science & Innovation Policy, FR, Atlanta)Communication dans un congrès avec actes -
Health innovation for rare diseases
(OECD Publishing, 2016)Chapitre d'ouvrage -
Sleeping Beauty awakened by self-citation of a review: a case study of Judah Folkman hypothesis on angiogenesis
(16th International Society of Scientometrics and Informetrics conference., CN, Wuhan, 2017-10-16)Communication dans un congrès avec actes -
How does Regulation Affect Beliefs? The Case of Stock Market Valuation of Orphan Drug Regulatory Approvals
(112th APSA Annual Meeting "Great Transformations: Political Science and the Big Questions of Our Time", US, Philadelphie, 2016-09-01)Communication dans un congrès avec actes -
Charles Dotter & the birth of Interventional Radiology: A sleeping beauty with a restless sleep
(15th International Conference on Scientometrics & Informetrics, TR, Istanbul)Communication dans un congrès avec actes -
Spectrum of PTCH1 Mutations in French Patients with Gorlin Syndrome
(Journal of Investigative Dermatology. vol. 121, n° 3, pp. 478-481, 2003-09)Article de revue -
La dysplasie cléido-crânienne : attitudes thérapeutiques et recommandations. À propos d'une observation clinique
(Actualités Odonto-Stomatologiques. n° 247, pp. 241-254, 2009-09)Article de revue -
Does Orphan Drug market exclusivity incentive sustains drug development for rare diseases ?
(12th European Conference on Health Economics, NL, Maastricht)Communication dans un congrès avec actes -
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma
(British Journal of Cancer. vol. 99, n° 2, pp. 364-370, 2008-07)Article de revue -
Gorlin syndrome presenting as prenatal chylothorax in a girl
(Prenatal Diagnosis. vol. 25, n° 11, pp. 997-999, 2005-11)Article de revue